IN2014DN09451A - - Google Patents

Info

Publication number
IN2014DN09451A
IN2014DN09451A IN9451DEN2014A IN2014DN09451A IN 2014DN09451 A IN2014DN09451 A IN 2014DN09451A IN 9451DEN2014 A IN9451DEN2014 A IN 9451DEN2014A IN 2014DN09451 A IN2014DN09451 A IN 2014DN09451A
Authority
IN
India
Prior art keywords
preparation
relates
present
vilazodone hydrochloride
crystalline vilazodone
Prior art date
Application number
Inventor
Prasenjit Das
Bindu Srivastava
Nitin Maheshwari
Hashim Nizar Poovanathil Nagoor Meeran
Mohan Prasad
Sudershan Kumar Arora
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Priority to IN9451DEN2014 priority Critical patent/IN2014DN09451A/en
Publication of IN2014DN09451A publication Critical patent/IN2014DN09451A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to a process for the preparation of crystalline vilazodone hydrochloride.
IN9451DEN2014 2012-04-16 2013-04-16 IN2014DN09451A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN9451DEN2014 IN2014DN09451A (en) 2012-04-16 2013-04-16

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1173DE2012 2012-04-16
IN9451DEN2014 IN2014DN09451A (en) 2012-04-16 2013-04-16
PCT/IB2013/053024 WO2013156935A1 (en) 2012-04-16 2013-04-16 Process for the preparation of crystalline vilazodone hydrochloride

Publications (1)

Publication Number Publication Date
IN2014DN09451A true IN2014DN09451A (en) 2015-07-17

Family

ID=48539326

Family Applications (1)

Application Number Title Priority Date Filing Date
IN9451DEN2014 IN2014DN09451A (en) 2012-04-16 2013-04-16

Country Status (4)

Country Link
US (1) US20150073148A1 (en)
EP (1) EP2838894A1 (en)
IN (1) IN2014DN09451A (en)
WO (1) WO2013156935A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9382233B2 (en) 2012-06-13 2016-07-05 Apotex Inc. Forms of vilazodone and processes for the preparation thereof
EP2900658A4 (en) * 2012-09-27 2016-07-13 Msn Lab Ltd METHODS AND POLYMORPHS OF 5- [4- [4- (5-CYANO-1H-INDOL-3-YL) BUTYL] -1-PIPERAZINYL] -2-BENZOFURAN CARBOXAMIDE AND ITS SALTS
WO2015037010A1 (en) * 2013-09-13 2015-03-19 Symed Labs Limited Preparation of vilazodone hydrochloride crystalline form iv
CN105820157B (en) * 2015-01-09 2021-05-25 石药集团中奇制药技术（石家庄）有限公司 Vilazodone hydrochloride crystal form and preparation method thereof
EP3870292A4 (en) 2018-10-26 2022-11-09 The Research Foundation for The State University of New York COMBINATION OF SEROTONIN-SPECIFIC RESUPPUT INHIBITOR AND SEROTONIN 1A RECEPTOR PARTIAL AGONIST TO REDUCE L-DOPA-INDUCED DYSKINESIA

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4333254A1 (en) 1993-09-30 1995-04-06 Merck Patent Gmbh Piperidines and piperazines
UA76758C2 (en) * 2001-06-19 2006-09-15 Мерк Патент Гмбх Polymorph forms of hydrochloride of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine
CN102875538A (en) * 2012-10-16 2013-01-16 北京诚创思达医药科技有限公司 Method for preparing vilazodone or hydrochloride thereof

Also Published As

Publication number Publication date
US20150073148A1 (en) 2015-03-12
WO2013156935A1 (en) 2013-10-24
EP2838894A1 (en) 2015-02-25

Similar Documents

Publication Publication Date Title
GB2518547B (en) Method for the preparation of high purity lignin
MX2015002487A (en) Process for the preparation of teneligliptin.
IL230594A0 (en) Process for preparing n-substituted 1h-pyrazole-5-carbonylchloride compounds
IL227872A0 (en) Process for preparing substituted n-phenylhydroxylamines
MX2014010433A (en) Novel crystalline form of sitagliptin sulfate.
IN2014DN06964A (en)
IN2013MU03070A (en)
IN2014DN09451A (en)
IN2013MU01113A (en)
MX2012010443A (en) Process for the preparation of 5-substituted 1-alkyltetrazoles.
ZA201405824B (en) Process for the preparation of substituted phenylpropanones
WO2014118606A3 (en) A novel process for the preparation of silodosin
WO2013072938A3 (en) Process for the preparation of roflumilast
SG11201501831WA (en) Aminoethylation process for producing aryloxyalkylene amine compounds
IN2013MU04056A (en)
MX2014003936A (en) Method for producing dithiine tetracarboximides.
WO2014170909A3 (en) Process for pomalidomide
WO2014041558A3 (en) Process for preparation of crystalline etoricoxib
PL2817305T3 (en) An improved process for the preparation of aprepitant
MX2013002395A (en) Method for producing dithiin-tetracarboximides.
IN2014DN07498A (en)
IL229669A0 (en) Process for preparation of 1,2,3 -triazole-4-carboxamides
IN2014CN02645A (en)
EP2906536A4 (en) An improved process for preparation of perindopril intermediate
MX2014002630A (en) Production of alkaloids without the isolation of intermediates.